China Money Network
Login
Join

GIC-Backed Chinese Biopharma Firm CStone Raises $284M In HK IPO

  • February 26, 2019 — 16:19 CST

This Data Is Locked!

This area is available only to Subscribers.

CStone Pharmaceuticals, a Chinese clinical-stage biopharmaceutical company, has raised about HK$2.23 billion (US$284.09 million) in an initial public offering on the Hong Kong stock exchange... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: